The effect of tazobactam on the pharmacokinetics and the antibacterial activity of piperacillin in dogs

International Journal of Pharmaceutics

Volumn 153, Issue 1, 1997, Pages 115-121

  Zaghloul, Iman ^a,b   Kuck, Nyda ^a   Yacobi, Avi ^a  

^a PFIZER INC   (United States)

^b KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

lactamase inhibitors; Minimum inhibitory concentrations; Pharmacokinetics; Piperacillin; Serum bactericidal titer; Tazobactam

Indexed keywords

PIPERACILLIN; TAZOBACTAM;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BACTERICIDAL ACTIVITY; DOG; DRUG BLOOD LEVEL; DRUG POTENTIATION; ESCHERICHIA COLI; INTRAVENOUS DRUG ADMINISTRATION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030874203     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00103-8     Document Type: Article

References (17)

1. Batra, V.K., Morrison, J.A., Lasseter, K.C., Joy, V.A., 1979. Piperacillin kinetics. Clin. Pharmacol. Ther. 26 (1), 41-53.
2. Eliopoulos, G.M., Klimm, K., Ferraro, M.J., Jacoby, G.A., Moellering, R.C., 1989. Comparative in-vitro activity of piperacillin combined with the β-lactamase inhibitor tezobactam (YTR 830). Diagn. Microbiol. Infect. Dis. 12, 481-488.
3. English, A.R., Retsema, J.A., Girard, A.E., Lynch, J.E., Baarth, W.E., 1978. CP55899, a β-lactamase inhibitor that extends the antibacterial spectrum of β lactams; initial bacteriological characterization. Antimicrob. Agents Chemother. 14, 414-419.
4. Fass, R.J., Prior, R.B., 1989. Comparative in-vitro activities of piperacillin-tazobactam end ticarcillin-clavulanate. Antimicrob. Agents Chemother. 33, 1268-1274.
5. Ganes, D., Batra, V., Faulkner, R., Greene, D., Haynes, J., Kuye, O., 1991. Effect of probenecid on the pharmacokinetics of piperacillin and tazobactam in healthy volunteers. Proc. Sixth Ann. Meet. Exposition, American Association of Pharmaceutical Scientists, Washington, DC,1991. Abstract PPDM 8293. Pharm. Res. 8, S299.
6. Gutman, L., Kitzis, M.D., Yamabe, S., Acar, J.F., 1986. Comparative evaluation of a new β-lactamase inhibitor, YTR830, combined with different β-lactam antibiotics against bacteria harboring known β-lactamases. Antimicrob. Agents Chemother. 29, 955-957.
7. Hunter, P.A., Coleman, K., Fisher, J., Tayler, D., 1980. In-vitro synergistic properties of clavulanic acid with ampicillin, amoxycillin and ticarcillin. J. Antimicrob. Chemother. 6, 455-470.
8. Jacobs, M.R., Aronoff, S.C., Johenning, S., Shlaes, D.M., Yamabe, S., 1986. Comparative activities of the β-Lactamase inhibitors YTR 830, clavulanate, and sulbactam combined with ampicillin and broad-spectrum penicillins against defined β-lactamase-producing aerobic gram negative bacilli. Antimicrob. Agents Chemother. 29, 980-985.
9. Kuck, N.A., Jacobus, N.V., Petersen, P.J., Weiss, W.J., Testa, R.T., 1989. Comparative in vitro and in vivo activities of piperacillin combined with the β-lactamase inhibitors tazobactam, clavulanic acid and sulbactam. Antimicrob. Agents Chemother. 33, 1964-1969.
10. Ocampo, A.P., Hoyt, K.D., Wadgaonkar, N., Carver, A.H., Puglisi, C.V., 1989. Determination of Tazobactam and piperacillin in Human plama, serum, bile and urine by gradient elusion reversed-phase high-performance liquid chromatography. J. Chromatogr. 496, 167-179.
11. Pearson, R.D., Steigbigel, R.T., Davis, H.T., Chapman, S.W., 1980. Method for reliable determination of minimal lethal antibiotic concentrations. Antimicrob. Agents Chemother. 18, 699-708.
12. Reller, L.B., Stratton, C.W., 1977. Serum dilution test for bactericidal activity. II. Standardization and correlation with antimicrobial assays and susceptibility test. J. Infect. Dis. 136, 196-204.
13. Sorgel, F., Kinzing, M., 1993. The chemistry, pharmacokinetics and tissue distribution of piperacillin/tazobactam. J. Antimicrob. Chemother. 31 (suppl A), 39-60.
14. Van der Auwera, P., Klastersky, J., 1990a. Study of the influence of protein binding on serum bactericidal titers and killing rates obtained in volunteers receiving ceftazidime, cefotaxime and ceftriaxone. J. Hosp. Infect. 15 (Suppl. A), 23-34.
15. Van der Auwera, P., Klastersky, J., 1990b. Serum bactericidal titers after cefoperazone and ceftazidime with and without amikacin: an ex vivo study. Drug Invest. 2, 44-52.
16. Verbist, L., 1978. In vitro activity of piperacillin, a new semisynthetic penicillin with an unusually broad spectrum of activity. Antimicrob. Agents Chemother. 13, 349-359.
17. Wise, R., Logan, M., Cooper, M., Andrews, J.M., 1991. Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin. Antimicrob. Agents Chemother. 35, 1081-1084.